The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 02, 2020

Filed:

Aug. 05, 2015
Applicant:

Ymir Genomics Llc, Cambridge, MA (US);

Inventors:

Patrick Shannon Pendergrast, Cambridge, MA (US);

Robert Scott Pendergrast, Chatham, NJ (US);

John Stephen Pendergrast, Stockholm, NJ (US);

Anna Irmina Markowska, Brookline, MA (US);

Assignee:

YMIR GENOMICS, LLC, Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/10 (2006.01); C07K 1/30 (2006.01); C07K 14/705 (2006.01); B01D 21/26 (2006.01); B01D 9/00 (2006.01); G01N 1/40 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1003 (2013.01); B01D 9/0054 (2013.01); B01D 21/26 (2013.01); C07K 1/30 (2013.01); C07K 1/303 (2013.01); C07K 1/306 (2013.01); C07K 14/705 (2013.01); G01N 1/4055 (2013.01); B01D 21/262 (2013.01); B01D 2009/0086 (2013.01);
Abstract

Compositions and methods for the isolation of protein-nucleic acid complexes and microvesicles (collectively referred to as 'bioparticles') released by mammalian cells into body fluids or cell culture media are provided. Isolated bioparticles of the invention contain biological molecules that are useful as diagnostic/prognostic biomarkers or for identification of therapeutic targets (e.g., disease or disorder-associated miRNAs). The isolation of biological molecules as described herein results in purification and concentration of the molecules. Methods for producing bio fluids that are free of detectable bioparticles, that are largely depleted of bioparticles, or that possess a reduced concentration of bioparticles compared to a bio fluid starting material (collectively termed 'bioparticle-depleted') are also provided. Isolation of bioparticle-depleted biofluid is useful, e.g., in experimental systems where it is desirable to use a biofluid that does not contain endogenous bioparticles, or has been substantially depleted of endogenous bioparticles, from the source material.


Find Patent Forward Citations

Loading…